[HTML][HTML] Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular …

…, MF Piepoli, D Scheinert, H Sievert… - European Journal of …, 2018 - ejves.com
… Katus, Juhani Knuuti, Jes Lindholt, Heinrich Mattle, Piotr Pieniazek, Massimo Francesco
Piepoli, Dierk Scheinert, Horst Sievert, Iain Simpson, Jakub Sulzenko, Juan Tamargo, Lale …

Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients

…, T Trepels, E Zadan, K Horvath, H Sievert - Journal of the American …, 2004 - jacc.org
Objectives : The purpose of this study was to investigate the incidence, morphology, and
clinical course of thrombus formation after catheter closure of intra-atrial shunts. Background : …

European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

C Pristipino, H Sievert, F D'ascenzo… - European Heart …, 2019 - academic.oup.com
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

…, J Sadowski, K Bartus, B Kapelak, A Walton, H Sievert… - The Lancet, 2009 - thelancet.com
… In the three participating Australian centres, we did 24-h ambulatory blood-pressure …
We compared 24-h ambulatory blood-pressure monitoring results with office blood-pressure …

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral …

…, V Riambau, M Roffi, J Röther, H Sievert… - European heart …, 2011 - academic.oup.com
Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

DR Holmes, VY Reddy, ZG Turi, SK Doshi, H Sievert… - The Lancet, 2009 - thelancet.com
Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the …

…, S Kar, MJ Price, B Whisenant, H Sievert… - Journal of the American …, 2014 - jacc.org
Sievert receives study honoraria, travel expenses, consulting fees <$25,000 from Abbott,
Access Closure, AGA, Angiomed, Aptus, Atrium, Avinger, Bard, Boston Scientific, Bridgepoint, …

Transcatheter aortic valve implantation: first results from a multi-centre real-world registry

…, E Grube, A Linke, H Sievert, H Eggebrecht… - European heart …, 2011 - academic.oup.com
Aims Treatment of elderly symptomatic patients with severe aortic stenosis and co-morbidities
is challenging. Transcatheter aortic valve interventions [balloon valvuloplasty and …

Global experience in cervical carotid artery stent placement

…, N Sakai, F Shawl, H Sievert… - Catheterization and …, 2000 - Wiley Online Library
The purpose of this article is to review and update the current status of carotid artery stent
placement in the world. Surveys to major interventional centers in Europe, North and South …

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from …

…, K Billinger, T Trepels, U Krumsdorf, H Sievert - Journal of the American …, 2005 - jacc.org
… All patients received aspirin (300 to 325 mg) twice a day and clopidogrel (75 mg) twice a
day 48 h before the procedure as well as antibiotic therapy 1 h before the intervention. After …